155 related articles for article (PubMed ID: 37014687)
1. Genotoxic and genoprotective effects of 1,4-dihydropyridine derivatives: a brief review.
Leonova E; Ryabokon N; Rostoka E; Borisovs V; Velena A; Bisenieks E; Duburs G; Dzintare M; Goncharova R; Sjakste N
Arh Hig Rada Toksikol; 2023 Mar; 74(1):1-7. PubMed ID: 37014687
[TBL] [Abstract][Full Text] [Related]
2. "Atypical" neuromodulatory profile of glutapyrone, a representative of a novel 'class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studies.
Misane I; Klusa V; Dambrova M; Germane S; Duburs G; Bisenieks E; Rimondini R; Ogren SO
Eur Neuropsychopharmacol; 1998 Dec; 8(4):329-47. PubMed ID: 9928926
[TBL] [Abstract][Full Text] [Related]
3. 1,4-dihydropyridine derivatives increase mRNA expression of
Dišlere K; Rostoka E; Bisenieks E; Duburs G; Paramonova N; Sjakste N
Arh Hig Rada Toksikol; 2021 Jun; 72(3):148-156. PubMed ID: 34187104
[TBL] [Abstract][Full Text] [Related]
4. Metal ions modify DNA-protecting and mutagen-scavenging capacities of the AV-153 1,4-dihydropyridine.
Leonova E; Ošiņa K; Duburs G; Bisenieks E; Germini D; Vassetzky Y; Sjakste N
Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep; 845():403077. PubMed ID: 31561891
[TBL] [Abstract][Full Text] [Related]
5. A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels.
Kwok TC; Hui K; Kostelecki W; Ricker N; Selman G; Feng ZP; Roy PJ
PLoS Genet; 2008 May; 4(5):e1000067. PubMed ID: 18464914
[TBL] [Abstract][Full Text] [Related]
6. Atypical 1,4-dihydropyridine derivatives, an approach to neuroprotection and memory enhancement.
Klusa V
Pharmacol Res; 2016 Nov; 113(Pt B):754-759. PubMed ID: 27234899
[TBL] [Abstract][Full Text] [Related]
7. Study of interaction of antimutagenic 1,4-dihydropyridine AV-153-Na with DNA-damaging molecules and its impact on DNA repair activity.
Leonova E; Rostoka E; Sauvaigo S; Baumane L; Selga T; Sjakste N
PeerJ; 2018; 6():e4609. PubMed ID: 29713564
[TBL] [Abstract][Full Text] [Related]
8. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.
Bladen C; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2014 Jul; 466(7):1355-63. PubMed ID: 24149495
[TBL] [Abstract][Full Text] [Related]
10. Dihydropyridines decrease X-ray-induced DNA base damage in mammalian cells.
Wojewódzka M; Gradzka I; Buraczewska I; Brzóska K; Sochanowicz B; Goncharova R; Kuzhir T; Szumiel I
Mutat Res; 2009 Dec; 671(1-2):45-51. PubMed ID: 19737572
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyridine Derivatives as Cell Growth Modulators In Vitro.
Bruvere I; Bisenieks E; Poikans J; Uldrikis J; Plotniece A; Pajuste K; Rucins M; Vigante B; Kalme Z; Gosteva M; Domracheva I; Velena A; Vukovic T; Milkovic L; Duburs G; Zarkovic N
Oxid Med Cell Longev; 2017; 2017():4069839. PubMed ID: 28473879
[TBL] [Abstract][Full Text] [Related]
12. Fused 1,4-dihydropyridines as potential calcium modulatory compounds.
Safak C; Simsek R
Mini Rev Med Chem; 2006 Jul; 6(7):747-55. PubMed ID: 16842124
[TBL] [Abstract][Full Text] [Related]
13. Identical inhibitory modulation of A-type potassium currents by dihydropyridine calcium channel agonists and antagonists.
Mlinar B; Enyeart JJ
Mol Pharmacol; 1994 Oct; 46(4):743-9. PubMed ID: 7969054
[TBL] [Abstract][Full Text] [Related]
14. Polyphenolic antioxidants mimic the effects of 1,4-dihydropyridines on neurotensin receptor function in PC3 cells.
Carraway RE; Hassan S; Cochrane DE
J Pharmacol Exp Ther; 2004 Apr; 309(1):92-101. PubMed ID: 14718582
[TBL] [Abstract][Full Text] [Related]
15. Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists.
Yamaguchi S; Okamura Y; Nagao T; Adachi-Akahane S
J Biol Chem; 2000 Dec; 275(52):41504-11. PubMed ID: 11022040
[TBL] [Abstract][Full Text] [Related]
16. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.
Bangalore R; Baindur N; Rutledge A; Triggle DJ; Kass RS
Mol Pharmacol; 1994 Oct; 46(4):660-6. PubMed ID: 7969044
[TBL] [Abstract][Full Text] [Related]
17. (+)-S-12967 and (-)-S-12968: 1,4-dihydropyridine stereoisomers with calcium channel agonistic and antagonistic properties in rat resistance arteries.
Prieto D; Mulvany MJ; Nyborg NC
Br J Pharmacol; 1991 Jul; 103(3):1703-8. PubMed ID: 1933134
[TBL] [Abstract][Full Text] [Related]
18. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
Kozlowski R; Ehrhard P; Fischli W; Osterrieder W; Holck M
J Pharmacol Exp Ther; 1986 Sep; 238(3):1084-91. PubMed ID: 2427686
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers protect against aluminium-induced DNA damage and block adaptive response to genotoxic stress in plant cells.
Achary VM; Parinandi NL; Panda BB
Mutat Res; 2013 Mar; 751(2):130-8. PubMed ID: 23313746
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives.
Takahashi D; Oyunzul L; Onoue S; Ito Y; Uchida S; Simsek R; Gunduz MG; Safak C; Yamada S
Biol Pharm Bull; 2008 Mar; 31(3):473-9. PubMed ID: 18310913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
